、安徽IVD集采限价温和，医药热点持续轮动医药生物-医药生物行业周报证券研究报告/行业周报2023年12月10日评级：增持（维持）[重Ta点bl公e_司Fi基na本nc状e]况分析师：祝嘉琦公司名称股价EPSPEPEG评级执业证书编号：S0740519040001电话：021-20315150药明康德76.0020222023E2024E2025E20222023E2024E2025E0.83买入Email：zhujq@zts.com.cn药明生物29.352.973.E314.215.4025.6022.9918.0614.070.84买入分析师：张楠智飞生物62.241.041.311.652.1028.2613.990.62买入执业证书编号：S07405230700053.146.0619.8122.4317.7510.28Email：zhangnan03@zts.com.cn3.784.7116.4713.21康龙化成29.150.770.961.241.6637.8930.2123.4717.570.97买入天坛生物31.220.530.680.831.0158.3945.7337.6931.052.14增持华润三九48.912.4...